Medtronic PLC (MDT)
83.66
+0.09
(+0.11%)
USD |
NYSE |
Mar 18, 16:00
83.99
+0.33
(+0.39%)
After-Hours: 20:00
Medtronic Debt to Equity Ratio: 0.4851 for Jan. 31, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
January 31, 2024 | 0.4851 |
October 31, 2023 | 0.4863 |
July 31, 2023 | 0.487 |
April 30, 2023 | 0.472 |
January 31, 2023 | 0.5457 |
October 31, 2022 | 0.512 |
July 31, 2022 | 0.4396 |
April 30, 2022 | 0.4577 |
January 31, 2022 | 0.4777 |
October 31, 2021 | 0.4917 |
July 31, 2021 | 0.5031 |
April 30, 2021 | 0.5117 |
January 31, 2021 | 0.5961 |
October 31, 2020 | 0.5971 |
July 31, 2020 | 0.5695 |
April 30, 2020 | 0.4878 |
January 31, 2020 | 0.4928 |
October 31, 2019 | 0.5061 |
July 31, 2019 | 0.5208 |
April 30, 2019 | 0.5051 |
January 31, 2019 | 0.5019 |
October 31, 2018 | 0.5041 |
July 31, 2018 | 0.502 |
April 30, 2018 | 0.5074 |
January 31, 2018 | 0.5731 |
Date | Value |
---|---|
October 31, 2017 | 0.5638 |
July 31, 2017 | 0.6699 |
April 30, 2017 | 0.6647 |
January 31, 2017 | 0.6496 |
October 31, 2016 | 0.643 |
July 31, 2016 | 0.6284 |
April 30, 2016 | 0.5931 |
January 31, 2016 | 0.7012 |
October 31, 2015 | 0.6821 |
July 31, 2015 | 0.6698 |
April 30, 2015 | 0.6756 |
January 31, 2015 | 1.418 |
October 31, 2014 | 0.6937 |
July 31, 2014 | 0.6542 |
April 30, 2014 | 0.6027 |
January 31, 2014 | 0.6203 |
October 31, 2013 | 0.6423 |
July 31, 2013 | 0.591 |
April 30, 2013 | 0.5596 |
January 31, 2013 | 0.6221 |
October 31, 2012 | 0.6668 |
July 31, 2012 | 0.6246 |
April 30, 2012 | 0.6011 |
January 31, 2012 | 0.5953 |
October 31, 2011 | 0.6137 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.4396
Minimum
Jul 2022
0.5971
Maximum
Oct 2020
0.5072
Average
0.498
Median
Debt to Equity Ratio Benchmarks
Boston Scientific Corp | 0.4718 |
Stryker Corp | 0.6989 |
Abbott Laboratories | 0.3803 |
Axonics Inc | 0.00 |
Reshape Lifesciences Inc | 0.00 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 90.84B |
Total Liabilities (Quarterly) | 38.84B |
Shareholders Equity (Quarterly) | 51.79B |
Current Ratio | 2.299 |
Net Debt Paydown Yield | 0.25% |